2-氨基取代噻唑基膦酸脂的合成

本文报导一系列2-氨基-5-取代-4-噻唑基膦酸酯和2-氨基-4-取代-5-噻唑基膦酸酯的合成. 这类化合物显示了一定的杀菌活性.     

2-氨基-5-取代基4-噻唑基膦酸酯的质谱研究

本文对一系列2-氨基-5-取代基-4-噻唑基膦酸酯进行了质谱研究,发现2-氨基-5-取代基-4-噻唑基膦酸酯的膦酰基中的烷基在碎裂过程中产生了一种新的γ-烷基重排反应,并且讨论了这类化合物的质谱碎裂行为,用电子轰击碰撞活化质量分析离子动能谱(EI-CA-MIKES)和高分辨精确质量测量技术(AMMT)作了进一步的研究。     

2-氨基取代噻唑基膦酸酯的合成

许多噻唑类化合物具有生物活性,有些已作为杀菌剂、除草剂在农业上得到应用。近年来还进行了α-氨基酸的类似物α-氨基膦酸的合成及其生物活性的研究。迄今为止,还未见有4-噻唑基膦酸酯类化合物的合成和生物活性方面的文献报道。本文报道一系列2-氨基-5-取代-4-噻唑基膦酸酯(1)和2-氨基-4-取代-5-噻唑基膦酸酯(2)的合成。这类化合物显示了一定的杀菌活性。 1由取代乙酰氯与亚磷酸三酯经Arbuzov反应得到的取代乙酰基膦酸三酯(3)与缩二硫脲的溴氢酸盐(4)、一定量的弱碱(如硫脲、乙酸钾)在乙醇中反应制得。溶剂和碱的强弱     

α-(2-噻唑基脲基)膦酸二苯酯的合成

报道了一种简便的合成取代脲基膦酸酯的通用的新方法。在二氯甲烷中,三乙胺为缚酸剂的条件下,α-氨基膦酸二苯酯与三聚光气反应形成α-异氰酸基膦酸酯2,2不经分离,直接与2-氨基(苯并)噻唑加成得到α-(2-噻唑基脲基)膦酸二苯酯3,产率55.0%-88.9%。     

N-(4-叔丁基-5-苄基噻唑-2-基)氨基乙酰胺的合成与抗肿瘤活性

采用衍生法,在N-[4-叔丁基-5-(4-氯苄基)噻唑-2-基]脂肪酰胺酰基的α-位,插入氨基,设计合成了N-(4-叔丁基-5-苄基噻唑-2-基)氨基乙酰胺衍生物.以4,4-二甲基-1-芳基-3-戊酮为原料,经4-叔丁基-5-苄基-2-氨基噻唑(3),再经氯乙酰化和取代反应得21个N-(4-叔丁基-5-苄基噻唑-2-基)氨基乙酰胺(1),其结构经~1H NMR、~(13)C NMR和元素分析确证.噻唑蓝(MTT)法体外抗肿瘤活性测试表明,该类新化合物对肺癌细胞(A549)、宫颈癌细胞(Hela)和乳腺癌细胞(MCF-7)具有抗肿瘤活性.其中N-[4-叔丁基-5-(胡椒基)噻唑-2-基]吗啉基乙酰胺(1t)对Hela细胞的抑制活性最好;对优选化合物1t进行了AO/EB双染和细胞周期实验,流式细胞仪分析表明,化合物1t可显著诱导肿瘤细胞凋亡,阻滞Hela细胞有丝分裂在S期.     

新型含2-取代-1,3-噻唑烷和噻唑环的亚胺类化合物的合成及生物活性

通过4-[(2-氰基亚胺基-1,3-噻唑烷-3-基)甲基]-2-氨基噻唑与取代苯甲醛的缩合反应, 合成了14个新型含2-取代- 1,3-噻唑烷和噻唑环的亚胺类化合物5. 所有化合物的结构均经1H NMR和元素分析确证, 并通过X射线单晶衍射分析测定了化合物5a的晶体结构. 初步生物活性试验结果表明, 部分目标化合物具有一定的杀菌活性和植物生长调节活性.     

含噻唑骨架的吲哚衍生物的有效合成

报道了以5-氯乙酰基吲哚酮(1)为原料,在绝对乙醇为溶剂的条件下,与硫脲(取代硫脲)制备5-(2-取代氨基噻唑-4-基)二氢吲哚-2-酮类化合物2a~2k,与硫代酰胺合成5-(2-取代噻唑-4-基)二氢吲哚-2-酮类化合物2l~2q.该反应操作简便、条件温和、收率良好.所有化合物未见文献报道,其结构经红外光谱、质谱、核磁氢谱(碳谱)及元素分析确认.     

噻唑硫磷的结构研究

噻唑硫磷(fosthiazate)是一种新型、高效的有机磷农药。它是由2-氧化噻唑烷与S-仲丁基-O-乙基硫代磷酰氯通过取代反应制得,其化学名为O-乙基-S-仲丁基-2-氧代-1,3-噻唑烷-3-基硫代膦酸酯,结构式如下：     

温和条件下[2-氨基-3-(苯并噻唑-2-基)-4H-色烯-4-基]膦酸酯衍生物的简便合成

含有不同取代基的(E)-2-(苯并噻唑-2-基)-3-(2-羟基苯基)丙烯腈与亚磷酸二苯酯在水中,无催化剂催化即可发生Michael加环/环化串联反应,可以高产率地生成相应的[2-氨基-3-(苯并噻唑-2-基)-4H-色烯-4-基]膦酸酯衍生物.同时,也尝试了水杨醛、2-(苯并噻唑-2-基)乙腈和亚磷酸二苯酯在Et_3N催化下的三组分一锅法反应合成相应的膦酸酯衍生物.     

N-芳亚甲基-4-(4-甲氧基苯基)-5-(1H-1,2,4-三唑-1-基)-1,3-噻唑-2-胺的合成与生物活性

通过2-氨基-4-(4-甲氧基苯基)-5-(1H-1,2,4-三唑-1-基)-1,3-噻唑与取代苯甲醛发生缩合,合成了一系列新型含三唑环的噻唑席夫碱类化合物.利用1H NMR和元素分析对所有化合物进行了结构表征.初步的毒性试验表明,部分标题化合物具有一定的抗肿瘤活性.     

Synthesis and structural features of 1,3,2,5-dioxaboraphosphorinane complexes with Pt(II) and Pd(II) salts

Complexes of composition L₂MCl₂ [M=Pt, R=H (I), Me (II), Ph (III)], and LMC1₂ [M=Pd, R=H (IV)] are prepared by reaction of 4,6-R₂-2,5-diphenyl-1,3,2,5-dioxaboraphosphorinanes (L) with MCl₂. Far-IR and³¹P NMR spectroscopy are used to demonstrate that I is cis whereas II and III are trans complexes in the solid. The conformational behavior of I is studied by³¹P and¹H NMR. The asymmetric form of I exhibits anomalous stability.Translated from Izvestiya Akademii Nauk SSSR, Seriya Khimicheskaya, No. 10, pp. 2309–2312, October, 1991.     

Substituent effects on indium-phosphorus bonding in (4-RC6H4S)3In.PR'3 adducts (R = H, Me, F; R' = Et, Cy, Ph): a spectroscopic, structural, and thermal decomposition study

The tris(arylthiolate)indium(III) complexes (4-RC(6)H(4)S)(3)In [R = H (5), Me (6), F (7)] were prepared from the 2:3 reaction of elemental indium and the corresponding aryl disulfide in methanol. Reaction of 5-7 with 2 equiv of the appropriate triorganylphosphine in benzene or toluene resulted in isolation of the indium-phosphine adduct series (4-RC(6)H(4)S)(3)In.PR'(3) [R = H, R' = Et (5a), Cy (5b), Ph (5c); R = Me, R' = Et (6a), Cy (6b), Ph (6c); R = F, R' = Et (7a), Cy (7b), Ph (7c)]. These compounds were characterized via elemental analysis, FT-IR, FT-Raman, solution (1)H, (13)C{(1)H}, (31)P{(1)H}, and (19)F (7a-c) NMR spectroscopy, and X-ray crystallography (5c, 6a, 6c, and 7a). NMR spectra show retention of the In-P bond in benzene-d(6) solution, with phosphine (31)P{(1)H} signals shifted downfield compared to the uncoordinated ligand. The X-ray structures show monomeric 1:1 adduct complexes in all cases. The In-P bond distance [2.5863(5)-2.6493(12) A] is influenced significantly by the phosphine substituents but is unaffected by the substituted phenylthiolate ligand. Relatively low melting points (88-130 degrees C) are observed for all adducts, while high-temperature thermal decomposition is observed for the indium thiolate reactants 5-7. DSC/TGA and EI-MS data show a two-step thermal decomposition process, involving an initial loss of the phosphine moiety followed by loss of thiolate ligand.     

Reduction of (imine)Pt(IV) to (imine)Pt(II) complexes with carbonyl-stabilized phosphorus ylides

A novel method is reported for generation of the difficult-to-obtain (imine)Pt(II) compounds that involves reduction of the corresponding readily available Pt(IV)-based imines by carbonyl-stabilized phosphorus ylides, Ph3P=CHCO2R, in nonaqueous media. The reaction between neutral (imino)Pt(IV) compounds [PtCl4[NH=C(Me)ON=CR1R2]2] [R1R2 = Me2, (CH2)4, (CH2)5, (Me)C(Me)=NOH], [PtCl4[NH=C(Me)ONR2]2] (R = Me, Et, CH2Ph), (R1 = H; R2 = Ph or C6H4Me; R3 = Me) as well as anionic-type platinum(IV) complexes (Ph3PCH2Ph)[PtCl5[NH=C(Me)ON=CR2]] [R2 = Me2, (CH2)4, (CH2)5] and 1 equiv of Ph3P=CHCO2R (R = Me, Et) proceeds under mild conditions (ca. 4 h, room temperature) to give selectively the platinum(II) products (in good to excellent isolated yields) without further reduction of the platinum center. All thus prepared compounds (excluding previously described Delta4-1,2,4-oxadiazoline complexes) were characterized by elemental analyses, FAB mass spectrometry, IR and 1H, 13C[1H], 31P[1H] and 195Pt NMR spectroscopies, and X-ray single-crystal diffractometry, the latter for [PtCl2[NH=C(Me)ON=CMe2]2] [crystal system tetragonal, space group P4(2)/n (No. 86), a = b = 10.5050(10) A, c = 15.916(3) A] and (Ph3PCH2CO2Me)[PtCl3(NCMe)] [crystal system orthorhombic, space group Pna2(1) (No. 33), a = 19.661(7) A, b = 12.486(4) A, c = 10.149(3) A]. The reaction is also extended to a variety of other Pt(II)/Pt(IV) couples, and the ylides Ph3P=CHCO2R are introduced as mild and selective reducing agents of wide applicability for the conversion of Pt(IV) to Pt(II) species in nonaqueous media, a route that is especially useful in the case of compounds that cannot be prepared directly from Pt(II) precursors, and for the generation of systematic series of Pt(II)/Pt(IV) complexes for biological studies.     

铁铂硫原子簇化合物的合成与结构研究 V: [MoFe3S4]类立方烷簇合物的转化反应和[Et4N]3[Mo2Fe6S8(SC6H4CH3-m)3Cl6]的晶体结构

具[MoFe2S4]类立方烷结构单元的双类立方烷化合物[Et4N]4[Mo2Fe7S8(SR)12](1a,R=Ph; 1b, R=tolyl-m)或单类立方烷化合物[MoFe3S4(dteR2)5](2a, R=Me; 2b, R=Et)与酰氯在乙腈中反应, 分别得到不含Fe桥的双类立方烷化合物(Et4N)3[Mo2Fe6S8(SR)3Cl6](3a, R=Ph; 3b, R=toly-m)与[MoFe3S4]骨架支解后的Fe(dteR2)2Cl(4a, R=Me; 4b, R=Et)。说明在相同反应条件下, [MoFe3S4]单元在1中比在2中稳定, 本文首次将1型与3型结构通过一步化学反应连系起来。3型化合物的产生得到X射线衍射测定及^1H NMR谱的证实。本文报道3b的单晶结构及3的^!H NMR数据, 3b属六方晶系, P63/m, a=1.6827(3), c=1.5951(16)nm; V=3.91158nm^3; Dc=1.491g/cm^3;Z=2; F(000)=1780; 偏离因子R=0.048, 化合物2与酰氯反应产生4, 由红外及紫外可见光谱证实。     

SYNTHESIS OF O,O-DIPHENYL [SUBSTITUTED (2-SELENOMORPHOLIN-4-YL-ACETYL AMINO)] ALKYL PHOSPHONATES

A series of O,O-diphenyl [substituted (2-selenomorpholin-4-yl-acetyl amino)] alkyl phosphonates were synthesized by the reactions of selenomorpholine with O,O-diphenyl 2-chloro- acetylamino alkyl phosphonates. The structures of all new compounds have been confirmed by ¹ H NMR, ³¹ P NMR, IR spectroscopy, Mass spectroscopy and elemental analyses.     

Selenium heterocycles. XXXVII . Synthesis of 4-(thiazol-4-yl)-1,2,3-selenadiazoles and 4-(selenazol-4-yl)-1,2,3-selenadiazoles

Starting from readily available 2-substituted-4-formylthiazoles and selenazoles, a series of 4-(2-aryl-4-selenazolyl)-1,2,3-selenadiazoles I and 4-(2-substituted-4-thiazolyl)-1,2,3-selenadiazoles II were prepared. Pyrolysis of compound II afforded (2-substituted-4-thiazolyl) acetylenes VII. Addition of potassium hydroxide pellets to an alcoholic solution of II gave 2-substituted-1,4-diselenafulvenes VIII. Decomposition of compound II with base followed by the addition of carbon disulfide gave 5-substituted 2-thioxo-1,3-thiaselenoles XI.     

有序介质中二苯甲酰甲烷的酮醇互变异构

用紫外光谱研究了三苯甲酰甲烷在β-环糊精及离子型和非离子型胶束介质中的酮醇互变异构性质,β-环糊精的引入或胶束的形成使酮醇异构平衡向烯醇式方向移动.结果表明,用二苯甲酰甲烷的酮醇互变异构性质能够表征有序介质的微环境性质,确定表面活性物质的临界胶束浓度.     

Deuterium-labeling and NMR study of the dearomatization of N-alkyl-N-benzyldiphenylphosphinamides through anionic cyclization: ortho and benzylic lithiation directed by complex-induced proximity effects

The mechanism of the anionic cyclization dearomatizing reaction of N-benzyl-N-methyldiphenylphosphinamide (1) upon treatment with s-BuLi in tetrahydrofuran (THF) at -90 degrees C has been analyzed by deuterium-labeling and natural abundance multinuclear magnetic resonance ((1)H, (2)H, (7)Li, (13)C, (31)P) studies. In the absence of coordinating cosolvents such as hexamethylphosphoramide (HMPA), eight major anionic species were identified, which allowed us to unravel the pathway of the metalation reaction. In agreement with the complex-induced proximity effect (CIPE) mechanism, the sequence of transformations emerging from this study involves the coordination of the lithium base to the P=O group of 1 to give four dimeric precomplexes whose NMR data are consistent with structures Va/Vb and VIIIa/VIIIb. The diastereomers Va/Vb are the precursors of the monomeric benzylic anion II, whereas the VIIIa/VIIIb diastereomers are assumed to undergo ortho deprotonation leading to anions I. Translocation from the ortho anion to the benzylic one is not observed. Intramolecular conjugate addition of anion II to the P-phenyl rings happens in a reversible way, affording the monomeric dearomatized anions III, IV, VI, and VII. The reaction progresses to yield a mixture containing only the species I, III, and IV. HMPA acts as a catalyst for the ortho-to-benzylic translocation and anionic cyclization reactions. Two-dimensional (2D) (7)Li,(31)P[(1)H] shift correlations and (7)Li[(31)P] NMR spectra proved to be crucial for the structural assignment of the anionic species. These techniques also demonstrated the diastereotopicity of the two achiral ligands involved in a dimer with s-BuLi (Vb) owing to the slow configuration inversion of the carbanion center.     

3-取代-6-吡唑基-1,2,4-三唑并[3,4-b]-1,3,4-噻二唑类衍生物的合成及生物活性

将5-取代吡唑-3-甲酸乙酯1位甲基化,经水解反应得到3种中间体1-甲基-5-取代1H-吡唑-3-甲酸（2a~2c）;以不同取代的羧酸为原料经一系列反应合成6种中间体3-取代4-氨基-5-巯基-1,2,4-均三唑（3a~3f）;将中间体（2a~2c）和（3a~3f）在三氯氧磷条件下反应,合成出18种1,2,4-三唑并[3,4-b]-1,3,4-噻二唑类化合物(4a~4r),均未见文献报道。 通过IR、1H NMR、13C NMR和元素分析表征了化合物结构。 初步的生物活性测试结果显示,所合成的化合物均表现出不同程度的生长素活性和抑菌活性。 并选取抑菌活性较好的两个化合物进行抗菌药物最低抑菌浓度(MIC)的测定。     

Synthesis and Characterization of Ferrocene Derived Cyclic Carbaphosphazenes

Dialkylamino substituted cyclic carbaphosphazenes, (R 2 NCN) 2 (NPCl 2 ) were prepared and reacted with the ferrocene derived hydroxymethyl phosphine sulfide FcCH(CH 3 )P(S)(CH 2 OH) 2 after dilithiation to yield a series of new spirocyclic derivatives of cyclic carbaphosphazenes having ferrocenyl pendant groups. To confirm the formation of six membered spirocycles and to compare their spectral features, transesterification reactions of FcCH(CH 3 )P(S)(CH 2 OH) 2 also were carried out with P(NR 2 ) 3 , yielding the six membered heterocycles FcCH 2 P(S)(CH 2 O) 2 PNR 2 (R = Me, Et). The compounds were characterized by 1 H, 31 P, 13 C NMR, mass spectra, and elemental analysis.